Subcutaneous alemtuzumab plus cyclosporine for the treatment of aplastic anemia

Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia

Norbert Frickhofen, H. Heimpel, J. P. Kaltwasser et al. · Blood · 2003 · 330 citations · Full text

Medicine, Hematology, Pharmacology +8

Epidemiology of aplastic anemia: a prospective multicenter study

Eva Montané, Luisa Ibáñez, Xavier Vidal et al. · Haematologica · 2008 · 208 citations · Full text

Medicine, Hematology, Pathology +15

The epidemiology of aplastic anemia in Thailand

Surapol Issaragrisil, David W. Kaufman, Theresa Anderson et al. · Blood · 2005 · 197 citations · Full text

Medicine, Hematology, Pathology +12

Drugs in the aetiology of agranulocytosis and aplastic anaemia

David W. Kaufman, Judith P. Kelly, Jan M. Jurgelon et al. · European Journal Of Haematology · 1996 · 191 citations

Medicine, Hematology, Pharmacology +6

Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration

G Hale, Peppy Rebello, Lee Brettman et al. · Blood · 2004 · 182 citations · Full text

Pharmacy, Immunology, Oncology +14